Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 1/20 | 0.40 |
| ▸ | MAOB | P27338 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | SIGMAR1 | Q99720 | 4/20 | 0.38 |
| ▸ | TYMP | P19971 | 1/20 | 0.38 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.38 |
| ▸ | ASPH | Q12797 | 1/20 | 0.38 |
| ▸ | KDM8 | Q8N371 | 1/20 | 0.38 |
| ▸ | ASAH1 | Q13510 | 5/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | MMP8 | P22894 | 1/20 | 0.36 |
| ▸ | KDM6B | O15054 | 1/20 | 0.36 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17844229 | 0.91 | MEN1 (0.48) | MAOAMAOBMEN1KMT2AL3MBTL1 | |
| SCHEMBL17844227 | 0.85 | POLB (0.39) | MEN1KMT2APOLB | |
| SCHEMBL3551960 | 0.84 | BRD4 (0.39) | MEN1KMT2AL3MBTL1POLB | |
| SCHEMBL5184329 | 0.81 | TYMP (0.42) | MAOAMAOBMEN1KMT2AL3MBTL1 | |
| SCHEMBL17844119 | 0.80 | TAAR1 (0.40) | MEN1KMT2AGPR84POLB | |
| SCHEMBL17844236 | 0.79 | DRD2 (0.44) | MEN1KMT2APOLB | |
| SCHEMBL17844244 | 0.79 | MTNR1A (0.40) | L3MBTL1 | |
| SCHEMBL17844176 | 0.78 | ADORA3 (0.35) | — | |
| SCHEMBL17844148 | 0.78 | KMT2A (0.40) | MEN1KMT2AL3MBTL1 | |
| SCHEMBL17844228 | 0.77 | CYP1A2 (0.43) | KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2016100619-A2 | TREATMENT AND DIAGNOSIS OF CANCER | RGENIX, INC. (US) | 2016-06-23 | — | — | WO | disclosed |